Alternative methods for analysis of radiographic damage in a randomized, double blind, parallel group clinical trial comparing hydroxychloroquine and sulfasalazine

Journal of Rheumatology

Volumn 27, Issue 2, 2000, Pages 535-539

  Van Der Heijde, Désirée M F M ^a   Van Riel, Piet L C M ^b   Nuver Zwart, Ike H ^b   Van De Putte, Levinus B A ^b  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b NONE

Author keywords

Clinical Trial; Methodology; Radiographic Damage; Radiography; Rheumatoid Arthritis; Scoring Method

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; GOLD; HYDROXYCHLOROQUINE; METHOTREXATE; PENICILLAMINE; SALAZOSULFAPYRIDINE;

ARTHROPATHY; ARTICLE; BONE EROSION; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RADIODIAGNOSIS; RANDOMIZED CONTROLLED TRIAL; RHEUMATOID ARTHRITIS; SCORING SYSTEM;

ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; DOUBLE-BLIND METHOD; HUMANS; HYDROXYCHLOROQUINE; RADIOGRAPHY; RANDOMIZED CONTROLLED TRIALS; SULFASALAZINE;

EID: 0033963090     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (5)

1. van der Heijde DM, van Riel PL, Nuver Zwart IH, Gribnau FW, van de Putte LB. Effects of hydroxychloroquine and sulphasalazine on progression of joint damage in rheumatoid arthritis. Lancet 1989;1:1036-8.
2. van der Heijde DM, van Riel PL, Nuver Zwart IH, van de Putte LB. Sulphasalazine versus hydroxychloroquine in rheumatoid arthritis: 3-year follow-up [letter]. Lancet 1990;335:539.
3. Nuver-Zwart H, van Riel P, van de Putte L, Gribnau F. A double blind comparative study of sulphasalazine and hydroxychloroquine in rheumatoid arthritis. Ann Rheum Dis 1989;48:389-95.
4. Sharp JT, Young DY, Bluhm GB, et al. How many joints in the hands and wrists should be included in a score of radiologic abnormalities used to assess rheumatoid arthritis? Arthritis Rheum 1985;28:1326-35.
5. Lassere M, Boers M, van der Heijde D, et al. Smallest detectable difference in radiological progression. J Rheumatol 1999; 26:731-39.